Conformational regulation of arrestin-mediated signaling
Conformational regulation of arrestin-mediated signaling
批准号:
7464846
负责人:
VSEVOLOD V. GUREVICH
金额:
$30.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2012-06-30
关键词:
AffectArrestinArrestinsAttenuatedBindingBinding SitesBiochemicalBiological AssayBiological PhenomenaBiological ProcessCellsCessation of lifeCharacteristicsChimera organismClassificationComplexCytoskeletonElectron Spin Resonance SpectroscopyElectronicsElectronsElementsG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGTP-Binding ProteinsGoalsIndividualLifeLightLocalizedMAPK1 geneMAPK10 geneMeasuresMediatingMethodsMicrotubulesMitogen-Activated Protein KinasesModelingMolecularMolecular ConformationNamesNaturePathway interactionsPhosphorylationPhosphotransferasesPlayPliabilityProcessPropertyProtein KinaseProtein Phosphatase 2A Regulatory Subunit PR53Protein phosphataseProteinsPublic HealthPurposeRangeRegulationRetinal ConeRhodopsinRoleSRC geneSignal TransductionSignaling MoleculeSignaling ProteinSiteSite-Directed MutagenesisSpecificitySpectrum AnalysisSpin LabelsStagingStimulusStructural ModelsStructureTestingTherapeuticVisualWorkarrestin3basedesensitizationdesignfunctional outcomesimprovedinhibitor/antagonistmdm2 proteinmutantpreferenceprotein-tyrosine kinase c-srcreceptorreceptor bindingreceptor internalizationretinal rodstoolubiquitin ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The decrease of cell responsiveness to a persistent stimulus, usually termed desensitization, is a widespread biological phenomenon. The signaling by G protein-coupled receptors (GPCRs) is attenuated by a two-step mechanism: receptor phosphorylation by a specific kinase followed by arrestin binding to active phosphoreceptor. Arrestin binding terminates G protein-mediated signaling, tags GPCRs for internalization, and redirects signaling to other pathways via non-receptor binding partners (c-Src and MAP kinases, ubiquitin ligases, etc). Arrestins also interact with microtubules via the same interface that is involved in receptor binding and mobilize several signaling molecules to the cytoskeleton with different functional consequences. The main objective of this proposal is to elucidate the structural basis of arrestin function as an organizer of multi-protein signaling complexes in the cell. We hypothesize that the signaling capability of arrestin molecule is determined by its conformation. We propose to identify arrestin elements involved in receptor and microtubule binding and the nature of receptor- and microtubule-induced conformational changes in both non- visual arrestins that regulate their interactions with non-receptor partners: kinases c-Src, ERK2, JNK3, ubiquitin ligase Mdm2, etc. To this end, we propose to use site-directed mutagenesis, direct binding assay, site-directed spin labeling of arrestins and EPR spectroscopy, as well as functional assays in living cells. We also propose to use double spin-labeled arrestins and spin-labeled arrestins with spin-labeled model receptor, rhodopsin, to measure inter-spin distances in arrestin-receptor complex by conventional EPR and double electron-electron resonance (DEER) to obtain a working structural model of the complex. This information will set the stage for designing arrestin-based molecular tools for targeted manipulation of cellular signaling that can be used for experimental and therapeutic purposes. PUBLIC HEALTH RELEVANCE: Arrestins are multi-functional adaptors that mobilize various signaling molecules to G protein-coupled receptors and microtubules with different functional consequences. The goal of this proposal is to elucidate the conformations of receptor-bound and microtubule-bound arrestins to understand how arrestin conformation affects its interactions with signaling proteins and the consequences of their binding. This information will set the stage for designing arrestin-based molecular tools for targeted manipulation of cellular signaling that can be used for experimental and therapeutic purposes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted Engineering of Designer Arrestins to Regulate Cell Signaling
-
批准号:9275751
-
项目类别:
-
资助金额:$34.14万
-
财政年份:2017
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Targeted Engineering of Designer Arrestins to Regulate Cell Signaling
-
批准号:9914303
-
项目类别:
-
资助金额:$56.5万
-
财政年份:2017
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Regulation of GPCR signaling with receptor-specific arrestins
-
批准号:9189631
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2015
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Regulation of GPCR signaling with receptor-specific arrestins
-
批准号:8985683
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2015
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Conformational regulation of arrestin-mediated signaling
-
批准号:7902981
-
项目类别:
-
资助金额:$27.9万
-
财政年份:2009
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Conformational regulation of arrestin-mediated signaling
-
批准号:7680992
-
项目类别:
-
资助金额:$29.55万
-
财政年份:2008
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Conformational regulation of arrestin-mediated signaling
-
批准号:7884252
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2008
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Conformational regulation of arrestin-mediated signaling
-
批准号:8076870
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2008
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Arrestin interactions with non-receptor binding partners
-
批准号:8458058
-
项目类别:
-
资助金额:$28.51万
-
财政年份:2007
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Arrestin interactions with non-receptor binding partners
-
批准号:7765525
-
项目类别:
-
资助金额:$27.35万
-
财政年份:2007
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Arrestin interactions with non-receptor binding partners
-
批准号:7367994
-
项目类别:
-
资助金额:$27.63万
-
财政年份:2007
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Arrestin interactions with non-receptor binding partners
-
批准号:8625763
-
项目类别:
-
资助金额:$29.55万
-
财政年份:2007
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Arrestin interactions with non-receptor binding partners
-
批准号:8295479
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2007
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Arrestin interactions with non-receptor binding partners
-
批准号:7265502
-
项目类别:
-
资助金额:$27.61万
-
财政年份:2007
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Arrestin interactions with non-receptor binding partners
-
批准号:7578331
-
项目类别:
-
资助金额:$27.63万
-
财政年份:2007
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Arrestin interactions with non-receptor binding partners
-
批准号:7496684
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2007
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Molecular mechanisms of arrestin function
-
批准号:6520494
-
项目类别:
-
资助金额:$25.07万
-
财政年份:2001
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Molecular mechanisms of arrestin function
-
批准号:6531979
-
项目类别:
-
资助金额:$17.73万
-
财政年份:2001
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Molecular mechanisms of arrestin function
-
批准号:6723635
-
项目类别:
-
资助金额:$25.07万
-
财政年份:2001
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
Molecular mechanisms of arrestin function
-
批准号:6321945
-
项目类别:
-
资助金额:$5.28万
-
财政年份:2001
-
负责人:VSEVOLOD V. GUREVICH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
坡模酸通过抑制β-arrestin2介导的M2型巨噬细胞极化抗肝纤维化的机制研究
-
批准号:2026JJ81069
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱萱
-
依托单位:
电针刺激ST36通过DRD1/β-arrestin1信
号通路抑制炎症性骨丢失的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:刘冠峤
-
依托单位:
电针激活β-arrestin 1/IFN通路促进“冷-热”免疫表型转化协同IDO抑制剂治疗MSS肠癌的机制研究
-
批准号:
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:时佳琪
-
依托单位:
电针激活β-arrestin 1/IFN通路促进"冷-热"免疫表型转化协同IDO抑制剂治疗MSS肠癌的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:时佳琪
-
依托单位:
催产素系统通过β-arrestin2下调IL-25表达改善IBS-D肠道低度炎症的机制研究
-
批准号:82300613
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:于祎昂
-
依托单位:
GRK3激活β-arrestin-网格蛋白促进EGFR内吞导致结直肠癌西妥昔单抗治疗耐药的机制研究
-
批准号:82303846
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李源
-
依托单位:
CB2R-β-arrestin1抑制小胶质细胞代谢重编程调控神经炎症在改善POCD中的机制研究
-
批准号:82360227
-
项目类别:地区科学基金项目
-
资助金额:32.2万元
-
批准年份:2023
-
负责人:张列亮
-
依托单位:
L-dopa通过外泌体miRNA-301b靶向调控β-arrestin2下调激活D1R信号通路参与帕金森病异动症的机制研究
-
批准号:LZ23H090001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:谢成龙
-
依托单位:
GPR120通过β-Arrestin2介导糖尿病性ED阴茎海绵体内皮损伤修复机制的研究
-
批准号:82371633
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:林浩成
-
依托单位:
基于GPR43/β-arrestin2通路探讨八正散调节肠道菌群介导短链脂肪酸代谢抑制肾结石氧化应激反应的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位: